EE Impact

BGI Group

China · Pharma & Healthcare

LeaveRussia detail: Continue Operations

Still operating in Russia

BGI Group, formerly Beijing Genomics Institute, is a Chinese genomics company with headquarters in Yantian District, Shenzhen. The company was originally formed in 1999 as a genetics research center to participate in the Human Genome Project. It also sequences the genomes of other animals, plants and microorganisms.

Status last verified 03/08/2026Source checked 06/03/2023Company website ↗LeaveRussia profile ↗

Decision trail

Decision date 03/03/2023 · Reference ↗

The US has imposed export restrictions on 37 companies, nearly 30 of them Chinese, for activities that include aiding the Russian military and supporting China's PLA. The restrictions affected divisions of the Chinese genetics company BGI and the Chinese cloud computing company Inspur.

Status history since 2022

  1. 03/08/2026 operating · Imported from KSE LeaveRussia

Exposure profile

Full exposure profile is a Professional feature

Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.

Upgrade to Professional
Statuses, logos and narrative notes are compiled from public reporting and the KSE LeaveRussia project. Found an error? See our corrections policy.